Skinvisible

Skinvisible EBIT per Employee

The EBIT per Employee of Skinvisible (SKVI) as of Oct 20, 2026 is -248,157.50 USD. In the previous year, EBIT per Employee was -294,794.50 USD — a change of -15.82% (higher).

EBIT per Employee

-248,157.50USD

YoY

-15.82%

Last updated:

EBIT per Employee of Skinvisible is 2025 -248,157.50 USD. EBIT per Employee of Skinvisible was 2024 -294,794.50 USD. It decreases by -15.82% higher compared to the previous year.

The Skinvisible EBIT per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Employee
Date
EBIT per Employee
Jan 1, 2018
-298,967.50 USD
Jan 1, 2019
-269,888.50 USD
Jan 1, 2020
-126,832.50 USD
Jan 1, 2021
94,040.00 USD
Jan 1, 2022
-119,216.00 USD
Jan 1, 2023
-245,187.50 USD
Jan 1, 2024
-294,794.50 USD
Jan 1, 2025
-248,157.50 USD
The Skinvisible EBIT per Employee history
YEAREBIT per EmployeeYoY
-248,157.50USD-15.82%
-294,794.50USD+20.23%
-245,187.50USD+105.67%
-119,216.00USD-226.77%
94,040.00USD-174.15%
-126,832.50USD-53.01%
-269,888.50USD-9.73%
-298,967.50USD+64.20%
-182,079.50USD-56.74%
-420,852.00USD-22.10%
-540,273.50USD-7.35%
-583,117.50USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Skinvisible Stock analysis

What does Skinvisible do? Skinvisible Inc develops and patents the Invisicare polymer delivery system, which enhances the delivery of active ingredients in topical skin care products. The company has formulated over forty topical skin products using Invisicare, with Pivotal being the patented technology that enables extended duration of active ingredients on the skin. Invisicare specifically carries water-insoluble and certain cationic active ingredients in water-based products without alcohol, silicones, waxes, or organic solvents. The firm's revenue comes from licensing the Invisicare technology to partners who develop and sell skin care products incorporating this delivery system. Skinvisible Inc's primary customers are pharmaceutical and cosmetic companies seeking to improve the efficacy of their topical skin care formulations. These companies purchase the Invisicare technology to integrate into their own product lines, leveraging the extended delivery duration and compatibility with water-based formulations. The company does not sell end-user products but focuses on technology licensing for partners who manufacture and market the final skin care products. The business model relies on the patent protection of Invisicare, which allows Skinvisible to generate revenue through licensing agreements. Partners pay for the right to use the technology in their products, with the company's focus on developing and protecting the polymer delivery system as its core asset. The firm's product portfolio includes over forty topical skin products developed using Invisicare, but these are not sold directly by Skinvisible Inc. Skinvisible is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Skinvisible stock

EBIT per Employee of Skinvisible is -248,157.50 USD in 2025.

EBIT per Employee of Skinvisible changed from -294,794.50 USD to -248,157.50 USD, representing a -15.82% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Employee Skinvisible since 2006 – with annual values, charts, and detailed analysis.

EBIT per employee measures operating profit per employee, showing how efficiently the workforce generates operating earnings.

EBIT per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT per Employee's Skinvisible historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — Skinvisible

All Key Metrics — Skinvisible